pf-07321332
Showing 1 - 4 of 4
Bioavailability Trial in New Haven (PF-07321332/ritonavir, PF-07321332)
Completed
- Bioavailability
- PF-07321332/ritonavir
- PF-07321332
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Jun 28, 2022
COVID-19 Trial in Worldwide (PF-07321332, Placebo for PF-07321332, Placebo for Ritonavir)
Completed
- COVID-19
- PF-07321332
- +3 more
-
Pelham, Alabama
- +168 more
Jul 6, 2022
COVID-19 Trial in Worldwide (PF-07321332, Ritonavir, Placebo)
Active, not recruiting
- COVID-19
- PF-07321332
- +2 more
-
Pelham, Alabama
- +336 more
Jul 21, 2022